A 44-year-old man with profound behavioural changes

Canadian Journal of Neurological Sciences

Volumn 39, Issue 4, 2012, Pages 527-530

  Laforce, R ^a   Kerchner, G A ^b   Rabinovici, G D ^a   Fong, J C ^a   Miller, B L ^a   Seeley, W W ^a   Grinberg, L T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BEHAVIOR CHANGE; CASE REPORT; DEPRESSION; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; MEDICAL HISTORY; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 84863334031     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100014086     Document Type: Article

References (5)

1. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456-77.
2. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie iR. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132:2922-31.
3. Snowden JS, Hu q, Rollinson S, et al. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol. 2011;122:99-110.
4. Urwin H, Josephs KA, Rohrer JD, et al. FUS pathology defines the majority of tau-and TDp-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120:33-41.
5. Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24:375-98.